OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human umbilical cord-derived mesenchymal stem cells ameliorate experimental colitis by normalizing the gut microbiota
Fan Yang, Beibei Ni, Qiuli Liu, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 23

Showing 23 citing articles:

Phytochemicals and Regulation of NF-kB in Inflammatory Bowel Diseases: An Overview of In Vitro and In Vivo Effects
Lucas Fornari Laurindo, Ana Rita de Oliveira dos Santos, Antonelly Cassio Alves de Carvalho, et al.
Metabolites (2023) Vol. 13, Iss. 1, pp. 96-96
Open Access | Times Cited: 65

Human umbilical cord mesenchymal stem cells ameliorate colon inflammation via modulation of gut microbiota-SCFAs-immune axis
Airu Liu, Xiaonan Liang, Wenxin Wang, et al.
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 26

Therapeutic Prospects of Mesenchymal Stem Cell and Their Derived Exosomes in the Regulation of the Gut Microbiota in Inflammatory Bowel Disease
Yaru Qiao, Xiaohua Tang, Ziyue Liu, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 607-607
Open Access | Times Cited: 8

Mesenchymal Stromal Cells: New Generation Treatment of Inflammatory Bowel Disease
Shulin Wei, Mingxing Li, Qin Wang, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 3307-3334
Open Access | Times Cited: 7

Medicinal Plants, Phytochemicals and Regulation of the NLRP3 Inflammasome in Inflammatory Bowel Diseases: A Comprehensive Review
Rosa Direito, Sandra Maria Barbalho, Maria Eduardo Figueira, et al.
Metabolites (2023) Vol. 13, Iss. 6, pp. 728-728
Open Access | Times Cited: 16

Comparison of different sources of mesenchymal stem cells: focus on inflammatory bowel disease
Lingyi Shi, Leilei Chen, Xizhuang Gao, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 3, pp. 1721-1742
Closed Access | Times Cited: 5

Exploring the Potential of Stem Cells in Modulating Gut Microbiota and Managing Hypertension
Asma Ismail Mahmod, Kayatri Govindaraju, Yogeswaran Lokanathan, et al.
Stem Cells and Development (2025)
Closed Access

Interplay between inflammatory bowel disease therapeutics and the gut microbiome reveals opportunities for novel treatment approaches
Catherine O’Reilly, Susan Mills, Mary C. Rea, et al.
Microbiome Research Reports (2023) Vol. 2, Iss. 4
Open Access | Times Cited: 9

LSR targets YAP to modulate intestinal Paneth cell differentiation
Yanan An, Chao Wang, Baozhen Fan, et al.
Cell Reports (2023) Vol. 42, Iss. 9, pp. 113118-113118
Open Access | Times Cited: 7

Human umbilical cord mesenchymal stem cells alleviated TNBS-induced colitis in mice by restoring the balance of intestinal microbes and immunoregulation
Yanxia Fu, Chen Zhang, Hui Xie, et al.
Life Sciences (2023) Vol. 334, pp. 122189-122189
Closed Access | Times Cited: 6

Allogenic Umbilical Cord-Derived Mesenchymal Stromal Cells Sustain Long-Term Therapeutic Efficacy Compared With Low-Dose Interleukin-2 in Systemic Lupus Erythematosus
Zhouli Cao, D. Wang, Lijuan Jing, et al.
Stem Cells Translational Medicine (2023) Vol. 12, Iss. 7, pp. 431-443
Open Access | Times Cited: 5

Intraovarian injection of 3D-MSC-EVs-ECM gel significantly improved rat ovarian function after chemotherapy
Yaping Zhang, Dong Li, Yi Han, et al.
Reproductive Biology and Endocrinology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1

Bile Acids in Inflammatory Bowel Disease: From Pathophysiology to Treatment
Samantha Hsieh, Arun Chandnani, Siyan Cao
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2910-2910
Open Access | Times Cited: 1

Short-Term Clinical Response and Changes in the Fecal Microbiota and Metabolite Levels in Patients with Crohn’s Disease After Stem Cell Infusions
Fan Yang, Xiaofang Zheng, Weicheng Liang, et al.
Stem Cells Translational Medicine (2023) Vol. 12, Iss. 8, pp. 497-509
Open Access | Times Cited: 3

Impact of Mesenchymal Stem Cells on the Gut Microbiota and Microbiota Associated Functions in Inflammatory Bowel Disease: A Systematic Review of Preclinical Evidence on Animal Models
Airu Liu, Chenyang Li, Chen Wang, et al.
Current Stem Cell Research & Therapy (2023) Vol. 19, Iss. 7, pp. 981-992
Closed Access | Times Cited: 3

Safety and Potential Efficacy of Expanded Umbilical Cord-Derived Mesenchymal Stromal Cells in Luminal Ulcerative Colitis Patients
Hanan Jafar, Dana A. Alqudah, Reem Rahmeh, et al.
Stem Cells and Development (2024)
Closed Access

Role of mesenchymal stem cells and short chain fatty acids in allergy: A prophylactic therapy for future
Mrudula M Mohanan, Radhakrishna Shetty, Claus Heiner Bang‐Berthelsen, et al.
Immunology Letters (2023) Vol. 260, pp. 1-10
Open Access | Times Cited: 1

Effect of electroacupuncture on gut microbiota and related inflammatory factors in rats with Crohn disease
Qiong Liu, Haolong He, Jingjing Yang, et al.
Journal of Acupuncture and Tuina Science (2023) Vol. 22, Iss. 1, pp. 12-21
Closed Access

Study Advances in the Treatment of Perianal Fistulizing Crohn’s Disease with Mesenchymal Stem Cells
亚珍 陈
Advances in Clinical Medicine (2023) Vol. 13, Iss. 04, pp. 5612-5620
Closed Access

Page 1

Scroll to top